Department of Pharmacology and Toxicology, Queen's University, Kingston, ON K7L 3N6, Canada.
Can J Physiol Pharmacol. 2010 Apr;88(4):480-6. doi: 10.1139/y10-004.
Recombinant truncated forms of heme oxygenase-1 and -2 (HO-1 and HO-2) were compared with their crude microsomal counterparts from brain and spleen tissue of adult male rats with respect to their inhibition by azole-based, nonporphyrin HO inhibitors. The drugs tested were an imidazole-alcohol, an imidazole-dioxolane, and a triazole-ketone. Both the recombinant and crude forms of HO-2 were similarly inhibited by the 3 drugs. The crude microsomal spleen form of HO-1 was more susceptible to inhibition than was the truncated recombinant form. This difference is attributed to the extra amino acids in the full-length enzyme. These observations may be relevant in the design of drugs as inhibitors of HO and other membrane proteins.
重组的血红素加氧酶-1 和 -2(HO-1 和 HO-2)的截断形式与来自成年雄性大鼠脑和脾组织的粗微粒体对应物进行了比较,以研究它们被基于唑的非卟啉 HO 抑制剂的抑制情况。测试的药物是咪唑醇、咪唑二恶烷和三唑酮。3 种药物均能相似地抑制重组和粗制形式的 HO-2。与截断的重组形式相比,粗微粒体脾脏形式的 HO-1 对抑制更为敏感。这种差异归因于全长酶中的额外氨基酸。这些观察结果在设计作为 HO 和其他膜蛋白抑制剂的药物时可能是相关的。